Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
Pharmacoepidemiology and Drug Safety|December 20, 2019
Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare DataMengdong He, Adrian J Santiago Ortiz, James Marshall, et al.
Pharmacoepidemiology and Drug Safety|September 13, 2013
Validation of claims-based algorithms for identification of high-grade cervical dysplasia and cervical cancerSeoyoung C Kim, Victoria G Gillet, Sarah Feldman, et al.
Seminars in Arthritis and Rheumatism|June 2, 2020
Validation of claims-based algorithms to identify interstitial lung disease in patients with rheumatoid arthritisSoo-Kyung Cho, Tracy J Doyle, Hemin Lee, et al.
Annals of the Rheumatic Diseases|March 13, 2014
Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort studySeoyoung C Kim, Robert J Glynn, Edward Giovannucci, et al.
Pharmacoepidemiology and Drug Safety|May 28, 2019
A tool for empirical equipoise assessment in multigroup comparative effectiveness researchKazuki Yoshida, Daniel H Solomon, Sebastien Haneuse, et al.
Annals of the Rheumatic Diseases|January 26, 2019
Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort studyAjinkya Pawar, Rishi J Desai, Daniel H Solomon, et al.
ACR Open Rheumatology|January 25, 2021
Identification of Acute Giant Cell Arteritis in Real-World Data Using Administrative Claims-Based AlgorithmsHemin Lee, Sara K Tedeschi, Sarah K Chen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 3, 2016
Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive MedicationsCandace H Feldman, Francisco M Marty, Wolfgang C Winkelmayer, et al.
Pageof 19